Study: Microarray CCP Scores Not a Substitute for qRT-PCR
Investigators conclude that microarray-generated cell cycle progression score should not be assumed to be a valid surrogate for qRT-PCR-generated scores.
Diagnosis & Disease Information
Auto-Injected Testosterone May Address Some TRT Shortcomings
Single-dose disposable auto injector approved for once-weekly subcutaneous administration of testosterone may cut down on potential problems associated with other options.
Bladder Cancer Immunotherapy May Change Urologic Practice
Promising results from clinical trials could encourage urologists to offer immunotherapy to their bladder cancer patients.
Telehealth Can Improve Patient Care, Help Practices Grow
Delivering care at a distance may enable practices to expand their current geographic boundaries and enhance patient satisfaction.
Social Media, Digital Marketing Key to Building Medical Practices
Active involvement in the digital ecosphere is vital to patient engagement.
PCR Test Bests Urine Cultures for UTI Pathogen Detection
A multiplex polymerase chain reaction assay detected bacteria species missed by traditional urine culture as well as more fastidious bacteria.
Shaping Federal Policy a Key Goal of LUGPA’s President-Elect
Chicago urologist Richard Harris, MD, says one of the biggest challenges facing independent urology practices is the constantly changing Medicare rules and regulations.
Prostate Cancer Focal Ablation Can Be a Reasonable Option
Patient selection and physician-patient commitment to careful follow-up surveillance are key.
‘Real-World’ Study Characterizes PCa Active Surveillance
Findings from a large contemporary cohort of men on active surveillance for prostate cancer shows that disease characteristics, not socioeconomic factors, are driving prostate cancer management.
2018 LUGPA Annual Meeting: What to Expect
The LUGPA 2018 Annual Meeting will take place from November 1-3, 2018, in Chicago, Illinois.
- Loading...
Loading...
Next post in LUGPA 2018 Annual Meeting
Loading... 
Loading...